FDA BIOD Oct 30, 2010 stockcharts.com/c-sc/sc?s=biod&p=D&yr=0&mn=6&dy=0&i=p00072939219&r=5375 Biodel (BIOD) Drug/indication: VIAject for diabetes Approval decision date: Oct. 30 VIAject is a fast-acting insulin analogue designed for absorption into the bloodstream that's faster than currently marketed rapid-acting insulins.